PYSZCZYMUKA GREG 4
4 · AYTU BIOPHARMA, INC · Filed Jan 2, 2025
Insider Transaction Report
Form 4
PYSZCZYMUKA GREG
Chief Commercial Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-12-31−208→ 209 total→ Common Shares (208 underlying) - Exercise/Conversion
Common Shares
2024-12-31+208→ 23,393 total
Footnotes (1)
- [F1]Restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on March 31, 2022, and vest quarterly beginning March 31, 2023 and ending March 31, 2025.